Each year, the American Association for Cancer Research’s conference spotlights promising early research into new approaches for attacking tumors. This year’s meeting, held in person …

Dive Brief: The Food and Drug Administration will decide whether to approve Bristol Myers Squibb’s cancer cell therapy Breyanzi for earlier use by late June, …